The Latest Breaking News from Vertex Pharmaceuticals Incorporated

Cooling inflation is raising hopes of a slower pace of rate hikes ahead. Moreover, experts now see chances of the economy avoiding a recession. Hence, investors could consider buying quality stocks, Comcast (CMCSA) and Vertex Pharmaceuticals (VRTX), to capitalize on their solid fundamentals. Read more.

Despite current market uncertainties, the U.S. economy's long-term growth prospects are pretty viable. Experts believe inflation will fall dramatically in the coming year, and robust growth will follow. Therefore, investors could buy quality stocks Microsoft (MSFT), Vertex Pharmaceuticals (VRTX), Centene (CNC), Agilent Technologies (A), and Myers Industries (MYE), which seem…

Gloomy earning guidance halted the S&P 500’s three-day winning streak. Moreover, a recession seems apparent as the U.S. economy battles sky-high inflation, aggressive rate hikes, and geopolitical headwinds. With the bear market not over yet, we think fundamentally strong stocks Walmart (WMT), Cisco Systems (CSCO), and Vertex Pharmaceuticals (VRTX) might…

The biotech industry is set to benefit from continued investments in breakthrough developments and federal support. Against this backdrop, fundamentally strong biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) could be solid buys. However, Relmada Therapeutics (RLMD) might be best avoided considering its weak fundamentals. Read on….

Government initiatives to expand domestic biotech production and research and rising private investments in advancing technologies are expected to boost the industry’s prospects. While we believe biotech stocks Vertex Pharmaceuticals (VRTX) and Biogen (BIIB) could be ideal investments for the long run, fundamentally weak Timber Pharmaceuticals (TMBR) might be best…

The biotech industry is expected to see solid growth in the long term due to rising healthcare spending, breakthrough developments, and an aging population. Given the industry’s solid growth prospects and non-cyclical nature, it could be wise to invest in fundamentally strong biotech stocks Gilead Sciences (GILD), Biogen (BIIB), Jazz…

In an uncertain market environment, investors must look for stocks that could win in the long run based on their strong fundamentals and solid growth prospects. We think Walmart (WMT), Tennant (TNC), Commvault Systems (CVLT), and Vertex Pharmaceuticals (VRTX) could be good choices on that front. Read on to learn…

Leading biotechnology company Vertex Pharmaceuticals (VRTX) has achieved strong top and bottom-line growth in its last quarter. Furthermore, the company is well-positioned to benefit from its diversified pipeline of transformative small-molecule, cell, and genetic therapies. Thus, even after gaining 27.5% year-to-date, we think VRTX still has decent upside potential. Read…

As the Biotech industry’s role in finding cures for chronic diseases and critical conditions is expected to keep attracting investors’ attention, it could be wise to scoop up shares of the fundamentally-strong biotech companies Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR), Amgen (AMGN), and Sino Biopharmaceutical (SBHMY) because of their solid…

The jitters over inflation's impact on the economy’s growth prospects have lately led to immense stock market volatility. Since the macroeconomic headwinds are not expected to ease anytime soon, we think it could be wise to invest in high-quality stocks Vertex Pharmaceuticals (VRTX), United Microelectronics (UMC), and Sanderson Farms (SAFM),…

The inelastic demand and rising investments in research and development should drive the pharmaceutical industry’s growth in the long run. Therefore, pharmaceutical stocks AbbVie (ABBV), Amgen (AMGN), Catalyst (CPRX), Novo Nordisk (NVO), and Vertex (VRTX), which possess sound fundamentals, could be solid long-term investments. These stocks are rated Strong Buy…